Back
Cognition Therapeutics Stock Price Chart
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
CGTX
Cognition Therapeutics
Last Price:
$0.43
Seasonality Move:
-7.25%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and CGTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cognition Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.39 | Buy |
| 20-day SMA: | 0.38 | Buy |
| 50-day SMA: | 0.44 | Sell |
| 200-day SMA: | 0.64 | Sell |
| 8-day EMA: | 0.4 | Buy |
| 20-day EMA: | 0.4 | Buy |
| 50-day EMA: | 0.44 | Sell |
| 200-day EMA: | 0.74 | Sell |
Cognition Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 56.93 | Buy |
| Chaikin Money Flow: | 302103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.34 - 0.44) | Buy |
| Bollinger Bands (100): | (0.39 - 0.69) | Sell |
Cognition Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cognition Therapeutics Stock
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.44 while CGTX 8-day simple moving average is 0.39, which is a Buy signal.
-
The stock price of CGTX is 0.44 while Cognition Therapeutics 20-day SMA is 0.38, which makes it a Buy.
-
Cognition Therapeutics 50-day simple moving average is 0.44 while CGTX share price is 0.44, making it a Sell technically.
-
CGTX stock price is 0.44 and Cognition Therapeutics 200-day simple moving average is 0.64, creating a Sell signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
37
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a SellThe current Cognition Therapeutics [CGTX] share price is $0.44. The Score for CGTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics Stock Info
Market Cap:
27.1M
Price in USD:
0.44
Share Volume:
427.1K
Cognition Therapeutics 52-Week Range
52-Week High:
2.95
52-Week Low:
0.31
Sell
37
Cognition Therapeutics (CGTX)
is a Sell
Cognition Therapeutics Share Price Forecast
-
What is the Cognition Therapeutics stock price today?The Cognition Therapeutics stock price is 0.44 USD today.
-
Will CGTX stock go up or go down?Cognition Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cognition Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics is overvalued.
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.44 while CGTX 8-day exponential moving average is 0.40, which is a Buy signal.
-
The stock price of CGTX is 0.44 while Cognition Therapeutics 20-day EMA is 0.40, which makes it a Buy.
-
Cognition Therapeutics 50-day exponential moving average is 0.44 while CGTX share price is 0.44, making it a Sell technically.
-
CGTX stock price is 0.44 and Cognition Therapeutics 200-day simple moving average is 0.74, creating a Sell signal.
Fundamental Analysis of Cognition Therapeutics
Is Cognition Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.02 per share, an increase this year of $0.39 per share, and an increase next year of $0.14 per share.
Technical Analysis of Cognition Therapeutics
Should I short Cognition Therapeutics stock?
-
CGTX Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Cognition Therapeutics is a Sell
-
Cognition Therapeutics Relative Strength Index (RSI) is 56.93, which suggest Cognition Therapeutics is overbought
-
The Bollinger Bands (25) for Cognition Therapeutics is (0.34 - 0.44), which suggest Cognition Therapeutics is a Sell
-
The Bollinger Bands (100) for Cognition Therapeutics is (0.39 - 0.69), which suggest Cognition Therapeutics is a Sell
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.